Caroline Power
Associate | Philadelphia
Caroline Power

Caroline Power is an associate in the product liability and mass torts group with a focus on developing scientific evidence, working with expert witnesses, coordinating parallel state and federal litigations, and preparing cases for trial. She has advised clients in the pharmaceutical, medical device, and manufacturing industries at all stages of litigation. Ms. Power has a particular interest in presenting complex medical and scientific issues to judges and juries in a way that is accessible, persuasive, and scientifically rigorous.

Ms. Power has experience in nearly every aspect of multi-district litigation, including initial internal investigation, case pool management, bellwether analysis and selection, discovery and case workup, motions practice, and trial. She has worked extensively with technical company witness and experts on issue ranging from medical causation, product development and testing, pharmacovigilance, manufacturing controls, and product distribution. She has prepared and defended company witness depositions, conducted the depositions of claimants and their healthcare providers, and prepared witnesses for providing trial testimony. She has experience serving on the Leadership Development Committee of a major MDL and is an active member of defense bar organizations.

Ms. Power maintains an active and varied pro bono practice. She serves as the co-chair of Dechert’s Philadelphia civil rights pro bono practice group and has served in partnership with the ACLU of Pennsylvania, E.D. Pennsylvania’s Volunteer Attorney Panel for Pro Se Cases, Philadelphia VIP, the Education Law Center, and the Juvenile Law Center. She recently received the Dechert Samuel E. Klein Pro Bono Award in recognition of her service.

Ms. Power is a regular contributor to the product liability and mass torts group’s newsletter, Dechert Re:Torts.

  • AbbVie in national product liability litigation related to its product Androgel, a testosterone replacement therapy. This litigation comprises an MDL in Chicago and additional cases in state courts in Mississippi, Illinois, Pennsylvania and Missouri.
  • Getinge AB and Atrium Medical Corporation in more than 2,400 personal injury lawsuits that have been filed involving their hernia mesh products, including an MDL in New Hampshire.
  • GlaxoSmithKline as lead national counsel in an ongoing MDL in the Southern District of Florida concerning the FDA’s market withdrawal of Zantac, an over-the-counter heartburn medication, due to concerns of alleged carcinogenicity.
  • Pfizer as National counsel in the Zoloft MDL, where hundreds of plaintiffs alleged that maternal use of Zoloft, an antidepressant, caused their children to be born with various birth defects. Dechert convinced the Court early in the litigation that the most efficient approach to the MDL would be to stage general causation ahead of other case specific issues. With that framework, Dechert successfully excluded all of plaintiffs’ general causation testimony and secured summary judgment in the entire MDL. The Third Circuit unanimously affirmed, cementing the resounding victory for Pfizer.
  • Takata Corporation in connection with civil litigation, criminal and NHTSA investigations and Congressional hearings related to airbags.
Services Industries
    • The Ohio State University, B.A., 2010, magna cum laude
    • Temple University, J.D., 2014, cum laude, National Trial Team, Member of the Temple International and Comparative Law Journal
    • Pennsylvania
    • New Jersey
    • United States District Court for the Eastern District of Pennsylvania
    • United States District Court for the Middle District of Pennsylvania